Company / Depreciation & Amortization
BIOMERICA INC Depreciation & Amortization History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$87.0K
FY2024
5-year range
$81.0K / $339.0K
FY2020-FY2024
Trend
+7.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization returned to growth in FY2024 after 2 years of decline, reaching $87,000.
Based on SEC 10-K filings.
$87,000 in FY2024 with a 5-year CAGR of -3.0%.
Increased from $84,000 to $87,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -36.5%
- 5-Year CAGR
- -3.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -3.0%, indicating a declining trend.
- In FY2024, depreciation & amortization increased 7.4% year-over-year.
- Peak depreciation & amortization was recorded in FY2021.
- Lowest depreciation & amortization in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $87.0K | +7.4% |
| FY2023 | $81.0K | -3.6% |
| FY2022 | $84.0K | -75.2% |
| FY2021 | $339.0K | +222.9% |
| FY2020 | $105.0K | +3.7% |
| FY2019 | $101.2K | +0.0% |
| FY2018 | $101.2K | -8.9% |
| FY2017 | $111.1K | -23.4% |
| FY2016 | $144.9K | -7.3% |
As of FY2024 · SEC Form 10-K · Last checked Jun 22, 2026